Published August 18, 2011
| Version v1
Patent
Open
Prognosis and Therapy Predictive Markers and Methods of Use
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention.
Files
US20110200998.pdf
Files
(1.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:1a43bc0a7ed7106da6f1723f487ce4d7
|
1.4 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 201113023331 A
- Patent application number
- US 2011/0200998 A1
- Other
- oai:uchicago.tind.io:9375
Dates
- Patent filed
-
2011-02-08